Special items: Ovarian Cancer and Us blog best viewed in Firefox

Wednesday, January 26, 2011

Takeda Pharma, Millennium commence (AMG386) TRINOVA-1 Phase III cancer (ovarian) trial

Takeda Pharmaceutical and the Takeda Oncology Company: Millennium, have commenced TRINOVA-1 Phase III clinical trial on anti-cancer agent AMG 386 in Japan

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.